GRP
STOK icon

Global Retirement Partners’s Stoke Therapeutics STOK Stock Holding History

Global Retirement Partners’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15K Buy
+35
New +$1.12K ﹤0.01% 4169
2025
Q4 		$1.11K Hold
35
– – ﹤0.01% 3868
2025
Q3 		$823 Buy
+35
New +$600 ﹤0.01% 3567

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Global Retirement Partners's STOK Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 35 shares worth $1.15K. The stake represents ﹤0.01% of the portfolio and ranks #4169 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in STOK as recently as Q4 2025.

Global Retirement Partners first reported a position in STOK in Q3 2025 and has held it in 3 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Global Retirement Partners held 35 shares of Stoke Therapeutics worth $1.15K as of Q2 2026.
  • Stoke Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Stoke Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4169 holding.
  • Global Retirement Partners first reported a position in Stoke Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.